6533b82bfe1ef96bd128d7dd

RESEARCH PRODUCT

Heart involvement in rheumatoid arthritis: systematic review and meta-analysis.

Rosario ScaglioneGiovanni PistoneLuigi CalvoSilvia MessinaCorrao SalvatoreGiuseppe Licata

subject

medicine.medical_specialtySettore MED/09 - Medicina InternaHeart Valve DiseasesPericardial effusionAsymptomaticArthritis RheumatoidInternal medicineMitral valvemedicineMitral valve prolapseHumansbusiness.industrymedicine.diseaseRheumatoid Arthritis Systematic review Meta-analysis Echocardiography assessment Pericardial disease Cardiac valvular calcificationSettore MED/45 - Scienze Infermieristiche Generali Cliniche E Pediatrichemedicine.anatomical_structureCardiovascular DiseasesEchocardiographyAortic valve stenosisRheumatoid arthritisMeta-analysisCase-Control StudiesCardiologymedicine.symptomCardiology and Cardiovascular MedicinebusinessCalcification

description

Abstract Objective The aim of our study was to conduct a systematic review with meta-analysis of the current case–control studies about the valvular and pericardial involvement in patients with Rheumatoid Arthritis (RA), asymptomatic for cardiovascular diseases. Methods Case–control studies were identified by searching PubMed (1975–2010) and the Cochrane Central Register of Controlled Trials (CENTRAL) (1975–2010). Participants were adult patients with RA asymptomatic for cardiovascular diseases, and the outcome measure was the presence of cardiac involvement. Results Quantitative synthesis included 10 relevant studies out of 2326 bibliographic citations that had been found. RA resulted significantly associated to pericardial effusion (OR 10.7; 95% CI 5.0–23.0), valvular nodules (OR 12.5; 95% CI 2.8–55.4), tricuspidal valve insufficiency (OR 5.3; 95% CI 2.4–11.6), aortic valve stenosis (OR 5.2; 95% CI 1.1–24.1), mitral valve insufficiency (OR 3.4; 95% CI 1.7–6.7), aortic valve insufficiency (OR 1.7; 95% CI 1.0–2.7), combined valvular alterations (OR 4.3; 95% CI 2.3–8.0), mitral valve thickening and/or calcification (OR 5.0; 95% CI 2.0–12.7), aortic valve thickening and/or calcification (OR 4.4; 95% CI 1.1–17.4), valvular thickening and/or calcification (OR 4.8; 95% CI 2.2–10.5), and mitral valve prolapse (OR 2.2; 95% CI 1.2–4.0). Conclusions Our systematic review pointed out the strength and the grade of both pericardial and cardiac valvular involvement in RA patients. Our findings underscore the importance of an echocardiographic assessment at least in clinical research when RA patients are involved. Moreover, further research is needed to understand the possible relationship of our findings and the increased cardiovascular mortality.

10.1016/j.ijcard.2012.05.057https://pubmed.ncbi.nlm.nih.gov/22703938